Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease

Neurobiology of Disease

Volumn 11, Issue 3, 2002, Pages 457-468

  Gonzalez Deniselle, María Claudia ^a   López Costa, Juan José ^b   Saavedra, Jorge Pecci ^b   Pietranera, Luciana ^a   Gonzalez, Susana L ^a   Garay, Laura ^a   Guennoun, Rachida ^c   Schumacher, Michael ^c   De Nicola, Alejandro F ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c INSERM   (France)

Author keywords

Amyotrophic lateral sclerosis; Neurodegeneration; Neuroprotection; Progesterone; Spinal cord; Wobbler mice

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); MESSENGER RNA; PROGESTERONE;

ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; DISEASE MODEL; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; FEMALE; GENE MUTATION; GOLGI COMPLEX; ION CURRENT; MALE; MEMBRANE POTENTIAL; MOTOR NEURON DISEASE; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD MOTONEURON;

EID: 0345578686     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0564     Document Type: Article

References (74)

1. Abe K., Morita S., Kikuchi T., Itoyama Y. Protective effect of a novel free-radical scavenger, OPC-14117, on wobbler mouse motor neuron disease. J. Neurosci. Res. 48:1997;63-70.
2. Azcoitia I., Fernández-Galaz C., Sierra A., Garcia-Segura L. M. Gonadal hormones affect neuronal vulnerability to excitotoxin-induced degeneration. J. Neurocytol. 28:2001;699-710.
3. Baulac M., Rieger F., Meininger V. The loss of motorneurons corresponding to specific muscles in the wobbler mutant mouse. Neurosci. Lett. 37:1983;99-104.
4. Blondet B., Ait-Ikhlef A., Murawsky M., Rieger F. Transient massine DNA fragmentation in nervous system during the early course of a murine neurodegenerative disease. Neurosci. Lett. 305:2001;202-206.
5. Boillee S., Viala L., Peschanski M., Dreyfus P. A. Differential microglial response to progressive neurodegeneration in the murine mutant Wobbler. Glia. 33:2001;277-287.
6. Boillee S., Berrutti G., Meccariello R., Grannec G., Razan F., Pierantoni R., Fasano S., Junier M. Early defect in the expression of mouse sperm DnaJ 1, a member of the DNAJ/heat shock protein 40 chaperone protein family, in the spinal cord of the wobbler mouse, a murine model of motoneuronal degeneration. Neuroscience. 113:2002;825835.
7. Brinton R. D. Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: Recent insight and remaining challenges. Learning Memory. 8:2001;121-133.
8. Chen J., Chopp M., Li Y. Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat. J. Neurol. Sci. 171:1999;24-30.
9. Chu-Wang I-W., Oppenheimer R. W. Cell death of motoneurons in the chick embryp spinal cord. J. Comp. Neurol. 177:1978;33-58.
10. Clarke P. G. H. Developmental cell death: Morphological diversity and multiple mechanisms. Anat. Embryol. 181:1990;195-213.
11. Clowry G. J., McHanwell S. Expression of nitric oxide synthase by motor neurons in the spinal cord of the mutant mouse wobbler. Neurosci. Lett. 215:1996;177-180.
12. Coulpier M., Junier M-P., Peschanski M., Dreyfus P. A. Bcl-2 sensitivity differentiates two pathways for motoneuronal death in the wobbler mutant mouse. J. Neurosci. 16:1996;5897-5904.
13. Cudkowicz M. E., Brown R. H. Amyotrophic lateral sclerosis and related motor neuron diseases. Jameson J. L. Principles of Molecular Medicine. 1998;907-911 Humana Press, Totowa.
14. De Nicola A. F. Steroid hormones and neuronal regeneration. Seil F. J. Advances in Neurology. 1993;199-206 Raven Press, New York.
15. Desarnaud F., Do Thi A. N., Brown A. M., Lemke G., Suter U., Baulieu E. E., Schumacher M. Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J. Neurochem. 71:1998;1765-1768.
16. Des Portes V., Coulpier M., Melki J., Dreyfus P. A. Early detection of mouse wobbler mutation: A model of pathological motoneuron death. Neuroreport. 5:1994;1861-1864.
17. Dikranian K., Ishimaru M. J., Tenkova T., Labruyere J., Qin Y. Q., Ikonomidou C., Olney J. W. Apoptosis in the in vivo mammalian forebrain. Neurobiol. Dis. 8:2001;359-379.
18. Dockery P., Tang Y., Morais M., Vacca-Galloway L. L. Neuron volume in the ventral horn in Wobbler mouse motoneuron disease: A light microscope stereological study. J. Anat. 191:1997;89-98.
19. Duchen L. W., Strick S. J. An hereditary motor neurone disease with progressive denervation of muscle in the mouse: The mutant " Wobbler " J. Neurol. Neurosurg. Psychiatry. 31:1968;535-542.
20. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24:1975;407-409.
21. González Deniselle M. C., Grillo C., González S., Roig P., De Nicola A. F. Evidence for down-regulation of GAP-43 mRNA in Wobbler mouse spinal motoneurons by corticosterone and a 21-aminosteroid. Brain Res. 841:1999a;78-84.
22. González Deniselle M. C., González S. L, Lima A., Wilkin G., De Nicola A. F. The 21-aminosteroid U-74389F attenuates hyperexpression of GAP-43 and NADPH-diaphorase in the spinal cord of Wobbler mouse, a model for amyotrophic lateral sclerosis. Neurochem. Res. 24:1999b;1-8.
23. González Deniselle M. C., González S., De Nicola A. F. Cellular basis of steroid neuroprotection in the Wobbler mouse, a model for motoneuron disease. Cell. Mol. Neurobiol. 21:2001;237-254.
24. González S., Grillo C., González Deniselle M. C., Lima A., McEwen B. S., De Nicola A. F. Dexamethasone up-regulates mRNA for Na,K-ATPase in some spinal cord neurons after cord transection. Neuroreport. 7:1996;1041-1044.
25. Guang-Ping X., Dave K. R., Moraes C. T., Busto R., Sick T. J., Bradley W. G., Perez-Pinzón M. A. Dysfunctional mitochondrial respiration in the wobbler mouse brain. Neurosci. Lett. 300:2001;141-144.
26. Gurney M. E., Cutting F. B., Zhai P., Doble A., Taylor C. P., Andrus P. K., Hall E. D. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;147-157.
27. Gurney M. E. What transgenic mice tell us about neurodegenerative disease. BioEssays. 22:2000;297-304.
28. Hall E. D., Andrus P. K., Oostveen J. A., Fleck T. J., Gurney M. E. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J. Neurosci. Res. 53:1998;66-77.
29. Hall E. D., Braughler J. M. Effects of intravenous methylprednisolone on spinal cord lipid peroxidation and (Na, K)-ATPase activity. Dose response analysis during 1st hour after contusion injury in the cat. J. Neurosurg. 49:1982;563-568.
30. Henderson J. T., Javaheri M., Kopko S., Roder J. C. Reduction of lower motor neuron degeneration in wobbler mice by n-acetyl-l-cysteine. J. Neurosci. 16:1996;7574-7582.
31. Henderson V. W. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology. 48:1997;S27-S28.
32. Ikeda K., Iwasaki Y., Kinoshita M. Neuronal nitric oxide synthase inhibitor, 7-nitroindazole, delays motor dysfunction and spinal motoneuron degeneration in the wobbler mouse. J. Neurol. Sci. 160:1998;9-15.
33. Ikeda K., Kinoshita M., Iwasaki Y., Tagaya N., Shiojima T. Lecithinized superoxide dismutase retards wobbler mouse motor neuron disease. J. Neurosci. Res. 48:1995;63-70.
34. Ikeda K., Iwasaki Y., Kinoshita M., Marubuchi S., Ono S. T-588, a novel neuroprotective agent, delays progression of neuromuscular dysfunction in wobbler mouse motoneuron disease. Brain Res. 858:2000;84-91.
35. Junier M. P., Coulpier M., Le Forestier N., Cadusseau J., Suzuki F., Peschanski M., Dreyfus P. A. Transforming growth factor alpha (TGF alpha) expression in degenerating motoneurons of the murine mutant Wobbler: A neuronal signal for astrogliosis? J. Neurosci. 14:1994;4206-4216.
36. Junier M. P., Legendre P., Esguerra C. V., Tinel M., Coulpier M., Dreyfus P. A., Bahr M. Regulation of growth factor gene expression in degenerating motoneurons of the murine mutant wobbler: A cellular patch-sampling/RT-PCR study. Mol. Cell. Neurosci. 12:1998;168-177.
37. Kaupmann K., Simon-Chazottes D., Guener J. L., Jokusch H. Wobbler, a mutation affecting motoneuron survival and gonadal functions in the mouse, maps to proximal chromosome 11. Genomics. 13:1992;39-43.
38. Koenig H. L., Schumacher M., Ferzaz B., Do Thi A. N., Ressouches A., Guennoun R., Jung-Testas I., Robel P., Akwa Y., Baulieu E. E. Progesterone synthesis and myelin formation by Schwann cells. Science. 268:1995;1500-1502.
39. Kong J., Zu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18:1998;3241-3250.
40. Krieger C., Perry T. L., Hansen S., Mitsumoto H., Honoré T. Excitatory amino acid receptor antagonist in murine motoneuron disease (Wobbler mouse). Can. J. Neurol. Sci. 19:1992;462-465.
41. Labombarda F., Gonzalez S., Roig P., Lima A., Guennoun R., Schumacher M., De Nicola A. F. Modulation of NADPH-diaphorase and glial fibrillary acidic protein by progesterone in astrocytes from normal and injured spinal cord. J. Steroid Biochem. Mol. Biol. 73:2000a;159-169.
42. Labombarda F., Guennoun R., Gonzalez S., Roig P., Lima A., Schumacher M., De Nicola A. F. Immunocytochemical evidence for a progesterone receptor in neurons and glial cells of the rat spinal cord. Neurosci. Lett. 288:2000b;29-32.
43. Labombarda F., Gonzalez S., Gonzalez Deniselle M. C., Guennoun R., Schumacher M., De Nicola A. F. Cellular basis for progesterone neuroprotection in the injured spinal cord. J. Neurotrauma. 19:2001;343-355.
44. Lees G. Inhibition of sodium-potassium-ATPase: A potencial ubiquitous mechanism contributing to central nervous system neurophatology. Brain Res. Rev. 16:1991;283-300.
45. Liere P., Akwa Y., Weill-Engerer S., Eychenne B., Pianos A., Robel P., Sjovall J., Schumacher M., Baulieu E. E. Validation of an analytical procedure to measure trace amounts of neurosteroids in brain tissue by gas chromatography-mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 10:2000;301-312.
46. Li M., Ona V. O., Guegan C., Chen M., Jackson-Lewis V., Andrews L. J., Olsewski A. J., Stieg P. E., Lee J. P., Przedborski S., Friedlander R. M. Functional role of caspace-1 and caspace-3 in an ALS transgenic mouse model. Science. 288:2000;335-339.
47. Mattson M. P. Modification of ion homeostasis by lipid peroxidation: Roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 20:1998;53-57.
48. Mc Ewen M. S:. The molecular and neuroanatomical basis for estrogen effects in the central nervous system. J. Clin. Endocrinol. Metab. 84:1999;1790-1797.
49. Meiri H. Is synaptic transmission modulated by progesterone? Brain Res. 385:1986;193-196.
50. Migheli A., Atzori C., Piva R., Tortarolo M., Girelli M., Schiffer D., Bendotti C. Lack of apoptosis in mice with ALS. Nat. Med. 5:1999;966-967.
51. Mitsumoto H., Bradley W. G. Murine motor neuron disease (the Wobbler mouse): Degeneration and regeneration of the lower motor neuron. Brain Res. 105:1982;811-834.
52. Morrison B. M., Janssen W. G., Gordon J. W., Morrison J. H. Time course of neuropathology in the spinal cord of G86R superoxide dismutase transgenic mice. J. Comp. Neurol. 391:1998;64-77.
53. Mourelatos Z., Gonatas N. K., Stieber A., Gurney M. E., Dal Canto M. C. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc. Natl. Acad. Sci. USA. 93:1996;5472-5477.
54. Murphy S. J., Traysman R. J., Hurn P. D. Progesterone exacerbates striatal stroke injury in progesterone-deficient female animals. Stroke. 31:2000;1173-1178.
55. Ogata T., Nakamura Y., Tsuji K., Shibata T., Kataoka K. Steroid hormones protect spinal cord neurons from glutamate toxicity. Neuroscience. 55:1993;445-449.
56. Pernas-Alonso R., Perrone-Capano C., Volpicelli F., di Porzio U. Regionalized neurofilament accumulation and motoneuron degeneration are linked phenotypes iin wobbler neuromuscular disease. Neurobiol. Dis. 8:2001;581-589.
57. Pollin M. M., McHanwell S., Slater C. R. Loss of motor neurons from the median nerve motor nucleus of the mutant mouse "wobbler" J. Neurocytol. 19:1990;29-38.
58. Popper P., Farber D. B., Micevych P. E., Minoofar K., Bronstein J. M. RTPM-2 expression and TUNEL staining in neurodegenerative diseases: Studies in wobbler and rd mice. Exp. Neurol. 143:1997;246-254.
59. Price D. L., Cleveland D. W., Koliatsis V. E. Motor neuron disease and animal models. Neurobiol. Dis. 1:1994;3-11.
60. Roof R., Hall E. Gender differences in acute CNS trauma and stroke: Neuroprotective effects and progesterone. J. Neurotrauma. 17:2000;367-388.
61. Roof R., Duvdevani R., Braswell L., Stein D. G. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp. Neurol. 129:1994;64-69.
62. Roof R., Hoffman S., Stein D. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol. Chem. Neuropathol. 31:1997;1-11.
63. Rupprecht R., Reul J. M. H. M., Trapp T., van Steensel B., Wetzel C., Damm K., Zieglgansberger W., Holsboer F. Progesterone receptor-mediated effects of neuroactive steroids. Neuron. 11:1993;523-530.
64. Schumacher M., Akwa I., Guennoun R., Robert F., Labombarda F., Desarnaud F., Robel P., De Nicola A. F., Baulieu E. E. Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J. Neurocytol. 29:2000;307-326.
65. Spooren W. P. J. M., Hengerer B. DNA laddering and caspace 3-like activity in the spinal cord cord of a mouse model of amyotrophic lateral sclerosis. Cell. Mol. Biol. 46:2000;63-69.
66. Stahl W. The Na,K-ATPase of nervous tissue. Neurochemistry. 8:1986;449-476.
67. Stein D. G., Fulop Z. L. Progesterone and recovery after traumatic brain injury: An overview. Neuroscientist. 4:1998;435-442.
68. Thomas A., Nockels R., Pan H., Shaffrey C., Chopp M. Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine. 24:1999;2134-2138.
69. Toran-Allerand C. D. Novel sites and mechanisms of oestrogen action in the brain. Novartis Found. Symp. 230:2000;56-69.
70. Tsuzaka K., Ishiyama T., Pioro E. P., Mitsumoto H. Role of brain-derived neurotrophic factor in wobbler motor neuron disease. Muscle Nerve. 24:2001;474-480.
71. Vongher J. M., Frye C. A. Progesterone in conjunction with estradiol has neuroprotective effects in a animal model of neurodegeneration. Pharmacol. Biochem. Behav. 64:1999;777-785.
72. Wong P. C., Pardo C. A., Borchelt D. R., Lee M. K., Copeland N. G., Jenkins N. A., Sisodia S. S., Cleveland D. W., Price D. L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Science. 271:1995;515-518.
73. Yu W. H. Survival of motoneurons following axotomy is enhanced by lactation or by progesterone treatment. Brain Res. 49:1989;379-382.
74. Yung K. K. L., Tang F., Vacca-Galloway L. L. Changes of neuropeptides in spinal cord and brain stem of Wobbler mouse at different stages of motoneuron disease. Neuroscience. 50:1982;209-222.